Company News - Yuanshan Group (00551.HK) reported a cumulative operating income of approximately $6.017 billion for the first nine months, a decrease of 1% year-on-year [2] - Baoshan International (03813.HK) recorded a cumulative operating income of 12.903 billion yuan for the first nine months, down 7.7% year-on-year [2] - Longyuan Power (00916.HK) achieved a cumulative power generation of 56,546,706 MWh in the first nine months, a decline of 0.53% year-on-year; excluding the impact of thermal power, there was a year-on-year increase of 13.81%, with wind power up 5.30% and solar power up 77.98% [2] Financial Performance - Qinhuangdao Port Co., Ltd. (03369.HK) reported a total throughput of 317 million tons for the first nine months, an increase of 5.56% year-on-year [3] - New China Life Insurance (01336.HK) expects net profit attributable to shareholders for the first three quarters to be between 29.986 billion yuan and 34.122 billion yuan, representing a year-on-year growth of 45% to 65% [3] - Jiangshan Holdings (00295.HK) reported a total power generation of approximately 238,787 MWh for the first nine months, a decrease of 4.83% year-on-year [3] - Morning News Technology (02000.HK) reported an unaudited revenue of 270 million HKD for the first nine months, down 7.6% year-on-year [3] - Dekang Agriculture and Animal Husbandry (02419.HK) sold approximately 7.5509 million pigs in the first nine months, with sales revenue of approximately 14.277 billion yuan [3] Drug Approvals and Developments - Hengrui Medicine (01276.HK) received a clinical trial approval notice for SHR-A2102, a targeted Nectin-4 antibody-drug conjugate (ADC) developed in-house; global sales for similar products are expected to reach approximately $1.949 billion in 2024 according to EvaluatePharma [3] - Hutchison China MediTech (00013.HK) plans to announce FRUSICA-2 registration study data at the 2025 European Society for Medical Oncology annual meeting [3] - CSPC Pharmaceutical Group (01093.HK) had its new drug application for Idaglutide α injection accepted by the National Medical Products Administration [3] Corporate Actions - Huazhen Medical (01931.HK) announced the acquisition of U.S. properties and the establishment of a U.S. subsidiary, ETHK BANK, to promote stablecoins and intellectual property securitization in the U.S. [3] - Lihigh Holdings (08472.HK) plans to invest 24 million HKD in cryptocurrency and commodities [3] - Hisense Home Appliances (00921.HK) and its subsidiaries subscribed to a financial product from Jingu Trust worth 1.739 billion HKD [3] Real Estate Performance - New Town Development (01030.HK) reported cumulative contract sales of 15.050 billion yuan for the first nine months, a decrease of 52.72% year-on-year [3] - Longfor Group (00960.HK) achieved total contract sales of 50.75 billion yuan in the first nine months [3] - CIFI Holdings Group (00884.HK) reported cumulative contract sales of approximately 13.06 billion yuan for the first nine months [3] - Ronshine China Holdings (03301.HK) reported contract sales of 3 billion yuan for the first nine months, down 45.3% year-on-year [3] - Yuzhou Group (01628.HK) reported cumulative sales of 4.913 billion yuan for the first nine months [3] - Yida China (03639.HK) reported contract sales of approximately 572 million yuan for the first nine months, down 24.74% year-on-year [3] Financing and Buyback Activities - Geely Automobile (00175.HK) was approved to issue debt financing instruments totaling no more than 10 billion yuan [3] - HSBC Holdings (00005.HK) repurchased 1.58 million HKD worth of shares at prices ranging from 102.2 to 103.77 HKD [3] - Xiaomi Group-W (01810.HK) repurchased 400 million HKD worth of shares at prices ranging from 47.82 to 50.55 HKD [3] - Shoucheng Holdings (00697.HK) repurchased 890 million HKD worth of shares at prices ranging from 2.21 to 2.27 HKD [3]

Core Viewpoint - In September, Ronshine China reported a total contract sales amount of approximately 302 million yuan, indicating ongoing activity in the real estate market despite broader economic challenges [1] Group 1: Sales Performance - The total contract sales amount for Ronshine China and its subsidiaries and joint ventures was about 302 million yuan in September [1] - The contracted building area was approximately 27,000 square meters [1] - The average contract price was around 11,200 yuan per square meter [1]

（原标题：融信中国(03301)前9个月总合约销售额约为30亿元 同比减少45.3%） 截至2025年9月30日止9个月，集团总合约销售额约为人民币30亿元，同比减少45.3%;集团总合约建筑面 积约为26.26万平方米;及集团平均合约售价约为每平方米1.14万元。 智通财经APP讯，融信中国(03301)发布公告，截至 2025年9月止1个月，集团总合约销售额约为人民币 3.02亿元，同比减少32.29%;集团合约建筑面积约为26,959平方米;及集团平均合约售价约为每平方米1.12 万元。 ...

截至2025年9月30日止9个月，集团总合约销售额约为人民币30亿元，同比减少45.3%;集团总合约建筑面 积约为26.26万平方米;及集团平均合约售价约为每平方米1.14万元。 融信中国(03301)发布公告，截至2025年9月止1个月，集团总合约销售额约为人民币3.02亿元，同比减少 32.29%;集团合约建筑面积约为26,959平方米;及集团平均合约售价约为每平方米1.12万元。 ...

Core Viewpoint -融信中国 announced its total contract sales and average contract price for the period ending September 2025, indicating a significant performance in the real estate market [1] Group 1: Sales Performance - The total contract sales amount to approximately RMB 3.02 billion for the month ending September 2025 [1] - For the nine months ending September 30, 2025, the total contract sales reached approximately RMB 30.02 billion [1] Group 2: Contract Area - The total contracted building area is approximately 26,959 square meters for the month ending September 2025 [1] - For the nine months ending September 30, 2025, the total contracted building area is approximately 262,559 square meters [1] Group 3: Average Contract Price - The average contract price is approximately RMB 11,186 per square meter for the month ending September 2025 [1] - For the nine months ending September 30, 2025, the average contract price is approximately RMB 11,433 per square meter [1]

Ronshine China Holdings Limited 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不 對 因 本 公 告 全部或任何部分內容而產生或因倚賴該等內容而引致的任何損失承擔任何責 任。 融信中國控股有限公司 （於 開 曼 群 島 註 冊 成 立 之 有 限 公 司） （股 份 代 號：3301） 二零二五年九月之未經審核營運數據 融信中國控股有限公司（「本公司」，連 同 其 附 屬 公 司 及 其 聯 合 營 公 司 統 稱 為「本 集 團」）董 事（「董 事」）會（「董事會」）欣 然 宣 佈 截 至 二 零 二 五 年 九 月 止 一 個 月，(i)本 集團總合約銷售額約為人民幣301,568,682元；(ii)本集團合約建築面積約為26,959 平 方 米；及(iii)本集團平均合約售價約為每平方米人民幣11,186元。 截 至 二 零 二 五 年 九 月 三 十 日 止 九 個 月，(i)本集團總合約銷售額約為人民幣 3,001,833,088元；(ii)本集團 ...

Core Viewpoint - The Hong Kong property stocks continue to decline, with significant drops observed in several major companies [1] Company Performance - RONSHINE CHINA (03301.HK) decreased by 6.25%, trading at HKD 0.18 [1] - SUNAC CHINA (01918.HK) fell by 3.13%, with a current price of HKD 1.55 [1] - R&F PROPERTIES (02777.HK) dropped by 3.03%, now priced at HKD 0.64 [1] - NEW CITY DEVELOPMENT (01030.HK) saw a decline of 2.94%, trading at HKD 2.31 [1]

Group 1 - The core viewpoint of the article indicates that Chinese property stocks continue to decline, with specific companies like R&F Properties, Sunac China, and others experiencing significant drops in their stock prices [1] - Standard & Poor's forecasts a year-on-year decline in new home sales in China by 8%, estimating sales to be between 8.8 trillion to 9 trillion RMB, which is a larger drop than the previously predicted 3% in May [1] - The report suggests that if demand stabilizes in first-tier cities, it could help sustain a recovery in demand, with expectations of a further decline in sales by 6% to 7% next year and a decrease in first-hand property prices by 1.5% to 2.5% [1] Group 2 - Shenwan Hongyuan predicts that the performance of property companies will remain under pressure in the third quarter, primarily due to continuous sales declines since 2021 leading to decreased settlements [1] - The impact of previous price cuts and promotions is expected to affect profit margins negatively, but there is an expectation for a weak recovery in the sector's performance between 2025 and 2026 as companies reach a bottom in profitability and asset impairments are cleared [1] - The report also notes that performance differentiation among companies is likely to intensify further [1]

Group 1 - The core viewpoint of the article indicates that Chinese property stocks continue to decline, with specific companies like R&F Properties and Sunac China experiencing significant drops in their stock prices [1] - Standard & Poor's forecasts a year-on-year decline in new home sales in China by 8%, estimating sales to be between 8.8 trillion to 9 trillion RMB, which is a larger drop than the previously predicted 3% in May [1] - The report suggests that if demand stabilizes in first-tier cities, it could help sustain a more consistent recovery in demand [1] Group 2 - Shenyin Wanguo predicts that the performance of real estate companies will remain under pressure in the third quarter, primarily due to continuous sales declines since 2021 leading to decreased settlements [1] - The article notes that previous price cuts and promotions have impacted current settlements, resulting in low profit margins [1] - However, it is anticipated that from 2025 to 2026, the sector's performance may see a weak recovery amidst bottoming out and that performance differentiation among companies will further intensify [1]

呈交日期: 2025年10月3日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 不適用 | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 03301 | 說明 | | | | | | | | | 法定/註冊股份數目 | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | 38,000,000,000 | HKD | 0.00001 | HKD | | 380,000 | | 增加 / 減少 (-) | | | 0 | | HKD | | 0 | | 本月底結存 | | 38,000,000,000 | HKD | 0.00001 | HKD | | 380,000 | FF301 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年9月30日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 融信中國控股有限公司（於開曼群島註冊成立之有限公司） 本月底法定/註冊股本總額： HKD ...